Aigen Investment Management LP Invests $2.99 Million in Danaher Co. (NYSE:DHR)

Aigen Investment Management LP purchased a new stake in Danaher Co. (NYSE:DHR - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 10,755 shares of the conglomerate's stock, valued at approximately $2,990,000. Danaher accounts for 0.6% of Aigen Investment Management LP's investment portfolio, making the stock its 20th biggest position.

A number of other large investors also recently made changes to their positions in the stock. CarsonAllaria Wealth Management Ltd. acquired a new stake in shares of Danaher in the 2nd quarter valued at about $25,000. nVerses Capital LLC acquired a new stake in Danaher during the second quarter worth approximately $25,000. MFA Wealth Advisors LLC acquired a new stake in Danaher during the second quarter worth approximately $51,000. Financial Connections Group Inc. acquired a new stake in shares of Danaher in the second quarter valued at approximately $51,000. Finally, Western Pacific Wealth Management LP acquired a new stake in shares of Danaher in the first quarter valued at approximately $55,000. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Stock Down 1.5 %

Shares of NYSE DHR traded down $3.66 during midday trading on Tuesday, hitting $239.59. The stock had a trading volume of 3,077,000 shares, compared to its average volume of 2,748,831. The business's 50 day moving average is $264.37 and its 200-day moving average is $260.82. The company has a market cap of $173.05 billion, a P/E ratio of 46.42, a PEG ratio of 4.51 and a beta of 0.85. Danaher Co. has a 52 week low of $193.75 and a 52 week high of $281.70. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm's revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.02 earnings per share. As a group, analysts predict that Danaher Co. will post 7.51 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. Danaher's dividend payout ratio (DPR) is 20.61%.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Stifel Nicolaus boosted their target price on shares of Danaher from $250.00 to $265.00 and gave the stock a "hold" rating in a research note on Wednesday, October 23rd. Bank of America lifted their target price on shares of Danaher from $270.00 to $275.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 24th. Wells Fargo & Company assumed coverage on shares of Danaher in a research note on Tuesday, August 27th. They set an "equal weight" rating and a $280.00 price target for the company. Robert W. Baird reduced their price objective on shares of Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a research note on Wednesday, October 23rd. Finally, Wolfe Research upgraded shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price target for the company in a research report on Thursday, October 31st. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $287.16.

Insiders Place Their Bets

In other Danaher news, SVP Georgeann Couchara sold 952 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 11.10% of the company's stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.